BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32910173)

  • 1. Role of levosimendan in weaning children requiring veno-arterial extracorporeal membrane oxygenation after cardiac surgery.
    Pan KC; Shankar S; Millar J; Chiletti R; Butt W; d'Udekem Y; Namachivayam SP
    Eur J Cardiothorac Surg; 2021 Jan; 59(1):262-268. PubMed ID: 32910173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of levosimendan on the outcome of veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis.
    Liu Y; Zhang L; Yao Y; Li Y; Qin W; Li Y; Xue W; Li P; Chen Y; Chen X; Guo H
    Clin Res Cardiol; 2024 Apr; 113(4):509-521. PubMed ID: 37217802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of Levosimendan on Veno-Arterial Extracorporeal Membrane Oxygenation Management and Outcome: A Systematic Review and Meta-Analysis.
    Kaddoura R; Omar AS; Ibrahim MIM; Alkhulaifi A; Lorusso R; Elsherbini H; Soliman O; Caliskan K
    J Cardiothorac Vasc Anesth; 2021 Aug; 35(8):2483-2495. PubMed ID: 33583718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis.
    Guilherme E; Jacquet-Lagrèze M; Pozzi M; Achana F; Armoiry X; Fellahi JL
    Crit Care; 2020 Jul; 24(1):442. PubMed ID: 32677985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levosimendan in patients undergoing extracorporeal membrane oxygenation after cardiac surgery: an emulated target trial using observational data.
    Massol J; Simon-Tillaux N; Tohme J; Hariri G; Dureau P; Duceau B; Belin L; Hajage D; De Rycke Y; Charfeddine A; Lebreton G; Combes A; Bouglé A
    Crit Care; 2023 Feb; 27(1):51. PubMed ID: 36750852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral versus central extracorporeal membrane oxygenation for postcardiotomy shock: Multicenter registry, systematic review, and meta-analysis.
    Mariscalco G; Salsano A; Fiore A; Dalén M; Ruggieri VG; Saeed D; Jónsson K; Gatti G; Zipfel S; Dell'Aquila AM; Perrotti A; Loforte A; Livi U; Pol M; Spadaccio C; Pettinari M; Ragnarsson S; Alkhamees K; El-Dean Z; Bounader K; Biancari F;
    J Thorac Cardiovasc Surg; 2020 Nov; 160(5):1207-1216.e44. PubMed ID: 31864699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of levosimendan on survival and weaning from ECMO after extracorporeal cardiopulmonary resuscitation.
    Gaisendrees C; Schlachtenberger G; Gerfer S; Krasivskyi I; Djordjevic I; Sabashnikov A; Kosmopoulos M; Jaeger D; Luehr M; Kuhn E; Deppe AC; Wahlers T
    Artif Organs; 2023 Aug; 47(8):1351-1360. PubMed ID: 37032531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of levosimendan use for venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis.
    Yang B; Zhao T; Guo B; Li Y
    Perfusion; 2023 Mar; 38(2):305-312. PubMed ID: 34689640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: Impact on the success of weaning and survival.
    Alonso-Fernandez-Gatta M; Merchan-Gomez S; Gonzalez-Cebrian M; Diego-Nieto A; Alzola E; Toranzo-Nieto I; Barrio A; Martin-Herrero F; Sanchez PL
    Artif Organs; 2021 Jul; 45(7):717-725. PubMed ID: 33377185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan's effect on venoarterial extracorporeal membrane oxygenation weaning.
    Hau M; Fong KM; Au SY
    Int J Artif Organs; 2022 Jun; 45(6):571-579. PubMed ID: 35570732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.
    Chen YW; Lee WC; Wu PJ; Fang HY; Fang YN; Chen HC; Tong MS; Sung PH; Lee CH; Chung WJ
    Front Cardiovasc Med; 2022; 9():912321. PubMed ID: 35845047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial.
    Ellouze O; Soudry Faure A; Radhouani M; Abou-Arab O; Besnier E; Moussa M; Cransac A; Ksiazek E; Fischer MO; Mertes PM; Bouhemad B; Guinot PG
    ESC Heart Fail; 2021 Aug; 8(4):3339-3347. PubMed ID: 34145993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of levosimendan on weaning and survival in adult cardiogenic shock patients with veno-arterial extracorporeal membrane oxygenation: systematic review and meta-analysis.
    Burgos LM; Seoane L; Furmento JF; Costabel JP; Diez M; Vrancic M; Aissaoui N; Benzadón MN; Navia D
    Perfusion; 2020 Sep; 35(6):484-491. PubMed ID: 32449494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal membrane oxygenation for intraoperative cardiac support in children with congenital heart disease.
    Delmo Walter EM; Alexi-Meskishvili V; Huebler M; Loforte A; Stiller B; Weng Y; Berger F; Hetzer R
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):753-8. PubMed ID: 20139198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment and transfer management of veno-arterial extracorporeal membrane oxygenation in patients with difficult downtime during cardiopulmonary bypass surgery].
    Fang K; Da H; Sun R; Wang J; Wang J; Jiang H; Wang T; Xu Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Apr; 36(4):415-421. PubMed ID: 38813638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central Veno-Arterial Extracorporeal Membrane Oxygenation (C-VA-ECMO) After Cardiothoracic Surgery: A Single-Center Experience.
    Rubino A; Costanzo D; Stanszus D; Valchanov K; Jenkins D; Sertic F; Fowles JA; Vuylsteke A
    J Cardiothorac Vasc Anesth; 2018 Jun; 32(3):1169-1174. PubMed ID: 29428358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of levosimendan on survival in patients undergoing extracorporeal membrane oxygenation after cardiovascular surgery.
    Distelmaier K; Roth C; Schrutka L; Binder C; Steinlechner B; Heinz G; Lang IM; Maurer G; Koinig H; Niessner A; Hülsmann M; Speidl W; Goliasch G
    Br J Anaesth; 2016 Jul; 117(1):52-8. PubMed ID: 27317704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of the initial SAPS II in veno-arterial extracorporeal oxygenation.
    Lee HS; Kim HS; Lee SH; Lee SA; Hwang JJ; Park JB; Kim YH; Moon HJ; Lee WS
    J Thorac Dis; 2019 Jan; 11(1):68-83. PubMed ID: 30863575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis.
    Bertini P; Paternoster G; Landoni G; Falcone M; Nocci M; Costanzo D; Brizzi G; Romani M; Esposito A; Guarracino F
    Minerva Cardiol Angiol; 2023 Oct; 71(5):564-574. PubMed ID: 35687316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and factors associated with early mortality in pediatric postcardiotomy veno-arterial extracorporeal membrane oxygenation.
    Jin Y; Feng Z; Zhao J; Hu J; Tong Y; Guo S; Zhang P; Bai L; Li Y; Liu J
    Artif Organs; 2021 Jan; 45(1):6-14. PubMed ID: 32645759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.